These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14267084)

  • 1. BETA-PROPIOLACTONE PLUS ULTRAVIOLET IRRADIATED PLASMA. A CLINICAL EVALUATION FOR HEPATITIS, TOXICITY AND ALLERGY.
    WOLFRAM BR; LOGRIPPO GA
    Bibl Haematol; 1964; 19():644-7. PubMed ID: 14267084
    [No Abstract]   [Full Text] [Related]  

  • 2. A TEN YEAR CLINICAL STUDY OF PLASMA TREATED WITH BETAPRONE AND COMBINED BETAPRONE PLUS ULTRAVIOLET IRRADIATION. COMPARISON WITH PRESENT METHODS OF TREATMENT.
    LOGRIPPO GA
    Pac Med Surg; 1964; 72():298-302. PubMed ID: 14208310
    [No Abstract]   [Full Text] [Related]  

  • 3. PROPIOLACTONE PLUS ULTRAVIOLET-TREATED PLASMA WITHOUT HEPATITIS. SIX YEARS' EXPERIENCE.
    LOGRIPPO GA; WOLFRAM BR; BRUSH BE
    Arch Surg; 1964 Apr; 88():721-4. PubMed ID: 14107028
    [No Abstract]   [Full Text] [Related]  

  • 4. HUMAN PLASMA TREATED WITH ULTRAVIOLET AND PROPIOLACTONE. SIX-YEAR CLINICAL EVALUATION.
    LOGRIPPO GA; WOLFRAM BR; RUPE CE
    JAMA; 1964 Mar; 187():722-6. PubMed ID: 14094292
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of combined treatment of serum containing hepatitis B virus with beta-propiolactone and ultraviolet irradiation.
    Stephan W; Berthold H; Prince AM
    Vox Sang; 1981 Sep; 41(3):134-8. PubMed ID: 7331286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [USE OF BETA-PROPIOLACTONE FOR THE STERILIZATION OF SOME TISSUE GRAFTS].
    MELNIKOVA VM; BELIKOV GP; PODKOLZIN VA
    Ortop Travmatol Protez; 1964 Apr; 25():33-6. PubMed ID: 14203551
    [No Abstract]   [Full Text] [Related]  

  • 7. [APPLICATION OF PRESERVED BONES STERILIZED IN BETA-PROPIOLACTONE, BASED ON 105 CASES].
    ZABORSZKY Z
    Orv Hetil; 1963 Nov; 104():2183-4. PubMed ID: 14106615
    [No Abstract]   [Full Text] [Related]  

  • 8. [POSSIBILITIES OF STERILIZATION OF BIOLOGICAL CULTURE-MEDIA INGREDIENTS WITH BETA-PROPIOLACTONE].
    VISCHER WA; BUEHLMANN X; BRUHIN H
    Pathol Microbiol (Basel); 1963; 26():515-23. PubMed ID: 14114125
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of the hepatitis safety of a beta-propiolactone/ultraviolet treated factor IX concentrate (PPSB).
    Heinrich D; Kotitschke R; Berthold H
    Thromb Res; 1982 Oct; 28(1):75-83. PubMed ID: 7157232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of hepatitis A virus added to pooled human plasma by beta-propiolactone treatment and ultraviolet irradiation.
    Frösner GG; Stephan W; Dichtelmüller H
    Eur J Clin Microbiol; 1983 Aug; 2(4):355-7. PubMed ID: 6313360
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined use of ultraviolet irradiation and beta propiolactone sterilization of sera infected with a virus.
    SMOLENS J; STOKES J
    Proc Soc Exp Biol Med; 1954 Jul; 86(3):538-9. PubMed ID: 13194713
    [No Abstract]   [Full Text] [Related]  

  • 12. Inactivation of hepatitis B and non-A, non-B viruses by combined use of Tween 80, beta-propiolactone, and ultraviolet irradiation.
    Prince AM; Stephan W; Kotitschke R; Brotman B
    Thromb Haemost; 1983 Aug; 50(2):534-6. PubMed ID: 6415846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effect of betapropiolactone/ultraviolet irradiation (BPL/UV) treatment of source plasma on hepatitis transmission by factor IX complex in chimpanzees.
    Prince AM; Stephan W; Brotman B; van den Ende MC
    Thromb Haemost; 1980 Dec; 44(3):138-42. PubMed ID: 7466740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus safety of beta-propiolactone treated plasma preparations. Clinical experiences.
    Heinrich D; Sugg U; Brackmann HH; Stephan W; Lissner R
    Dev Biol Stand; 1987; 67():311-7. PubMed ID: 3649316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum hepatitis and the clinical evaluation of blood components sterilized with beta-propiolactone.
    LOGRIPPO GA
    Bibl Haematol; 1962; 13():504-9. PubMed ID: 14466320
    [No Abstract]   [Full Text] [Related]  

  • 16. Inactivation of non-A, non-B virus infectivity by a beta propiolactone/ultraviolet irradiation treatment and Aerosil adsorption procedure used for preparation of a stabilized human serum.
    Prince AM; Stephan W; Brotman B
    Vox Sang; 1984; 46(2):80-5. PubMed ID: 6322448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of beta-propiolactone in disinfection and sterilization. (According to foreign investigations)].
    BAZHINOV AG; KAMORSKII NM
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Jul; 31():26-30. PubMed ID: 13688173
    [No Abstract]   [Full Text] [Related]  

  • 18. INFECTION OF THE ONE-DAY OLD FERTILE HEN'S EGG WITH RABIES VIRUS. VIII. BETA-PROPIOLACTONE INACTIVATED VACCINE PRODUCED BY INOCULATION OF ONE-DAY EGGS WITH NISHIGAHARA-O30-M (NOPM) STRAIN.
    YOSHINO K; SAITO K
    Arch Gesamte Virusforsch; 1963 Aug; 13():489-98. PubMed ID: 14078840
    [No Abstract]   [Full Text] [Related]  

  • 19. beta-propiolactone/ultraviolet irradiation: a review of its effectiveness for inactivation of viruses in blood derivatives.
    Prince AM; Stephan W; Brotman B
    Rev Infect Dis; 1983; 5(1):92-107. PubMed ID: 6828813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combined beta-propiolactone/ultraviolet irradiation treatment on hepatitis B virus.
    Prince AM; Stephan W
    Lancet; 1980 Oct; 2(8200):917. PubMed ID: 6107566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.